The Chapel Hill Town Council approved a brownfields agreement limiting how the town’s old police HQ property can be ...

No treatments currently exist for the fatty liver disease, but the market could be worth $40 billion in less than 10 years. While most interest was shown in Novartis’ oncology pipeline at its ...

Speaking at the event, the Chief Executive Officer of BeepAgro Africa, Gilead Okolonkwo ... Wednesday Onsite Training at its BeepAgro Africa HQ. As the event concluded with a symbolic cake ...

Gilead's HIV portfolio remains dominant but faces Medicare Part D pricing pressure, limiting future growth potential. New launches like Livdelzi provide growth opportunities but are unlikely to ...

The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year. Why: The stock's decline ...

Two weeks ago, Gilead Sciences released financial results for the fourth quarter of 2024, which exceeded even my most optimistic expectations. The strong performance of its HIV franchise was ...

Gilead said it plans to start phase 3 trials later this year. SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice ...

In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $111.77, changing hands for $112.26/share. When a stock reaches the ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

Advertisement Moss portrays June, or Offred, as she is called once she is forced to be a surrogate for a wealthy family under the totalitarian government known as Gilead. "We've been afraid of ...

At a news briefing in Geneva, UNAIDS Executive Director Winnie Byanyima said that the deal would involve Trump enabling the U.S. company Gilead to produce and license its “magical” prevention ...